Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 1,900 shares at $322.33 ($610K) on 2021-02-26, disclosed to the SEC on 2021-03-02.
Open-market sale of $610k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $315.62 | 100 | $32K | 5.2% |
| 2 | $317.52 | 100 | $32K | 5.2% |
| 3 | $319.67 | 300 | $96K | 15.7% |
| 4 | $321.21 | 400 | $128K | 21.1% |
| 5 | $321.21 | 400 | $128K | 21.1% |
| 6 | $322.33 | 600 |
| $193K |
| 31.7% |
| Total | $320.83 avg | 1,900 | $610K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |